(Reuters) – Drugmaker Pfizer Inc will request for an approval of its COVID-19 vaccine in Japan on Friday, Kyodo News reported, citing sources familiar with the move.
The Japanese government has a supply deal with Pfizer for 120 million vaccine doses. (https://bit.ly/2K4ntRV)
The United States and Britain have already begun administering the vaccine made by Pfizer and German partner BioNTech.
(Reporting by Dania Nadeem in Bengaluru; Editing by Shounak Dasgupta)
